Azimuth Pharma Limited
07916512
Some Concerns
- No accounts filed in last 18 months (-5)
- Going concern doubt noted in accounts (-10)
- 2 outstanding charges (-4)
Details
Compliance
Last accounts
30/09/2024
full
Next accounts due
30/06/2026
Confirmation statement
Last: 23/01/2026
Due 06/02/2027
Industry
Officers
director · Since 15/02/2024
CFO
BRITISH · UNITED KINGDOM · Age 41
Also on 15 other boards
director · Since 15/02/2024
CEO
BRITISH · UNITED KINGDOM · Age 52
Also on 19 other boards
Persons with Significant Control
Bioscript Limited
Suite A, Greenway House, Larkwood Way, Macclesfield, SK10 2XR
Reg: 13216692 · Companies House · Private Limited Company
Notified 13/07/2021
Former PSCs
Mr Graeme David Smith
Ceased 13/07/2021
Mr Matthew James Stanton
Ceased 07/11/2019
Charges2 outstanding
ALTER DOMUS TRUSTEES (UK) LIMITED (THE “SECURITY AGENT�)
ALTER DOMUS TRUSTEES (UK) LIMITED AS SECURITY AGENT.
CompanyRankvs 102830+ SIC 70100 peers30
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the directors with respect to going co
Key FinancialsYear ending 30/09/2024
Net Worth
£456k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
-£70k
Working capital
Current Assets
—
Current Liabilities
£70k
Fixed Assets
£527k
Tax at Year End(2021)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2024 | — | +£0 |
| 2023 | — | +£0 |
| 2022 | 0.00 | +£0 |
| 2021 | 0.00 | +£6k |
| 2021 | — | +£40k |
| 2020 | 0.00 | -£144k |
| 2019 | 27979.00 | — |
Derived from filed accounts. Not audited figures.